½ÃÀ庸°í¼­
»óǰÄÚµå
1454797

CO2 ÀÎÁ§ÅÍ ½ÃÀå : Á¦Ç° À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº°(ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

CO2 Injector Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Market Research Projections´Â ÃÖ±Ù CO2 ÀÎÁ§ÅÍ ½ÃÀå¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ºÐ¼®À» ¹ßÇ¥ÇÏ¿© ÁÖ¿ä ½ÃÀå ¿ªÇÐ, ¼ºÀå ÃËÁø¿äÀÎ, µµÀü °úÁ¦ ¹× ½ÅÈï µ¿Çâ¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2023³âºÎÅÍ 2030³â±îÁö ½ÃÀå ±ËÀûÀ» ¿¹ÃøÇÏ´Â ±ÍÁßÇÑ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÏ¿© CO2 ÀÎÁ§ÅÍÀÇ ¼¼°è »óȲÀ» Á¶¸íÇÕ´Ï´Ù.

¼¼°è CO2 ÀÎÁ§ÅÍ ½ÃÀåÀº ¿¬Æò±Õ 6.2% ¼ºÀåÇÏ¿© 2023³â 117¾ï ´Þ·¯¿¡¼­ 2030³â ¸»¿¡´Â 179¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • CO2 ÀÎÁ§ÅÍ ½ÃÀå ±Ô¸ð(2023³â ÃßÁ¤Ä¡) : 117¾ï ´Þ·¯
  • ¿¹»ó ½ÃÀå °¡Ä¡(2030³â ¿¹»ó) : 179¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2023-2030³â CAGR) : 6.2%.
  • °ú°Å ½ÃÀå ¼ºÀå·ü(2018-2022³â CAGR) : 4.5%.

CO2 ÀÎÁ§ÅÍ ½ÃÀå - º¸°í¼­ ¹üÀ§ :

CO2 ÀÎÁ§ÅÍ ½ÃÀå¿¡´Â À½·á ź»êÈ­, ¼®À¯ ÁõÁø ȸ¼ö(EOR), Æó¼ö ó¸®, ¿Â½Ç Àç¹è µî ´Ù¾çÇÑ ¿ëµµ¿¡ ÀÌ»êȭź¼Ò¸¦ ÁÖÀÔÇϱâ À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ ±â¼ú°ú ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀÎÁ§ÅÍ´Â »ê¾÷ °øÁ¤, ȯ°æ ÀÀ¿ë ¹× ³ó¾÷ °üÇà¿¡ ÀÌ»êȭź¼Ò¸¦ °ø±ÞÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº CO2 ±â¹Ý ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ȯ°æ ¹®Á¦¿¡ ´ëÇÑ °ü½É Áõ°¡, °øÁ¤ ÃÖÀûÈ­ ¹× È¿À²¼ºÀ» À§ÇØ CO2 ÁÖÀÔ¿¡ ÀÇÁ¸ÇÏ´Â »ê¾÷ÀÇ È®´ëÀÔ´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ¹ßÀüÀº ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ CO2 ÀÎÁ§ÅÍÀÇ Ã¤ÅÃÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, ½ÃÀåÀº ¿©ÀüÈ÷ ¿ªµ¿ÀûÀÔ´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ

¼¼°è CO2 ÀÎÁ§ÅÍ ½ÃÀåÀº ź¼Ò ȸ¼ö ¹× ÀúÀå(CCS) ±â¼ú äÅà Ȯ´ë, À½·á »ê¾÷ È®´ë, EOR Ȱµ¿ Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±âÈÄ º¯È­¿Í ¿Â½Ç°¡½º ¹èÃâ¿¡ ´ëÇÑ ¿ì·Á°¡ Ä¿Áö¸é¼­ CCS¸¦ ÅëÇØ CO2 ¹èÃâ·®À» ÁÙÀÌ·Á´Â °øµ¿ÀÇ ³ë·ÂÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â »ê¾÷ °øÁ¤¿¡¼­ ÀÌ»êȭź¼Ò¸¦ ȸ¼ö ¹× °Ý¸®Çϱâ À§ÇÑ CO2 ÀÎÁ§ÅÍ¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À½·á »ê¾÷Àº ÀÌ»êȭź¼Ò¸¦ ź»ê°¡½º¿¡ Ȱ¿ëÇϰí ÀÖ¾î CO2 ÀÎÁ§ÅÍ Á¦Á¶¾÷ü¿¡°Ô Å« ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼®À¯ ¹× °¡½º ºÐ¾ßÀÇ EOR ÀÀ¿ë ºÐ¾ß¿¡¼­ÀÇ CO2 »ç¿ëÀº ¼®À¯ ȸ¼öÀ²À» Áõ°¡½ÃÄÑ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

ÁÁÀº ½ÃÀå ȯ°æ¿¡µµ ºÒ±¸Çϰí, CO2 ÀÎÁ§ÅÍ ½ÃÀåÀº ³ôÀº ¼³Ä¡ ºñ¿ë, ±ÔÁ¦ À庮, ¹°·ù Á¦¾à µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, CO2 ÀÎÁ§ÅÍ ½Ã½ºÅÛÀÇ ÀÚº» Áý¾àÀû Ư¼º°ú Àü¹® ÀÎÇÁ¶ó ¹× ÀåºñÀÇ Çʿ伺ÀÌ Áß¼Ò±â¾÷(SME) ½ÃÀå ÁøÀÔÀ» °¡·Î¸·´Â Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÀÔ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, CO2 ¹èÃâ, ÀúÀå ¹× ¿î¼Û¿¡ ´ëÇÑ ±ÔÁ¦ÀÇ ºÒÈ®½Ç¼ºÀº ½ÃÀå È®´ë¸¦ °¡·Î¸·°í CCS ÇÁ·ÎÁ§Æ® ¹× CO2 Ȱ¿ë ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, CO2 Á¶´Þ, °ø±Þ¸Á °ü¸® ¹× À¯Åë°ú °ü·ÃµÈ ¹°·ù ¹®Á¦´Â ¿Üµý Áö¿ªÀ̳ª ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ CO2 ÀÎÁ§ÅÍÀÇ Ã¤ÅÃÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ :

¼¼°è CO2 ÀÎÁ§ÅÍ ½ÃÀåÀº Àç»ý¿¡³ÊÁö, ³ó¾÷ ¹× »ê¾÷ ºÐ¾ß¿¡¼­ »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù. Àç»ý °¡´É ¿¡³ÊÁö·ÎÀÇ Àüȯ¿¡ µû¶ó ¹ÙÀÌ¿À¸Å½º ¿¬¼Ò ½Ã ¹èÃâÀ» ¿ÏÈ­Çϱâ À§ÇØ CO2 ÁÖÀÔÀ» Ȱ¿ëÇϴ ź¼Ò ȸ¼ö ¹× ÀúÀå ¹ÙÀÌ¿À¿¡³ÊÁö(BECCS) ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ó¾÷ ºÐ¾ß¿¡¼­´Â ¿Â½Ç Àç¹è, Åä¾ç ź¼Ò °Ý¸®, ¹ÙÀÌ¿À¿¬·á »ý»êÀ» À§ÇÑ Á¶·ù ¹è¾çÀ» À§ÇÑ CO2 ÁÖÀÔ ±â¼úÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, CO2 ÀÎÁ§ÅÍÀº È­ÇÐ ÇÕ¼º, Æó¼ö ó¸®, pH Á¦¾î µîÀÇ »ê¾÷ °øÁ¤¿¡µµ Àû¿ëµÇ¾î ½ÃÀå È®´ë¿Í ±â¼ú Çõ½ÅÀÇ ´Ù¾çÇÑ ±æÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù.

º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ÇâÈÄ ¸î ³âµ¿¾È CO2 ÀÎÁ§ÅÍ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?
  • ´Ù¾çÇÑ »ê¾÷¿¡¼­ CO2 ÀÎÁ§ÅÍ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ÁøÈ­ÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ±â¼ú ¹ßÀüÀÌ ¼¼°è CO2 ÀÎÁ§ÅÍ ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¥ °ÍÀΰ¡?
  • CO2 ÀÎÁ§ÅÍ ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ´Â ÁÖ¿ä ±â¾÷Àº?
  • CO2 ÀÎÁ§ÅÍ ºÐ¾ß ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ÀÀ¿ë ºÐ¾ß ¹× ÃÖÁ¾ »ç¿ëÀÚ »ê¾÷Àº ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • Á¦Ç°¼ö¸íÁֱ⠺м®
  • CO2 ÀÎÁ§ÅÍ ½ÃÀå : ¹ë·ùüÀÎ
    • ¿øÀç·á °ø±Þ¾÷ü ¸®½ºÆ®
    • Á¦Á¶¾÷ü ¸®½ºÆ®
    • À¯Åë¾÷ü ¸®½ºÆ®
    • ¿ëµµ ¸®½ºÆ®
    • ¼öÀͼº ºÐ¼®
  • Porter¡¯s Five Forces ºÐ¼®
  • ÁöÁ¤ÇÐÀû ±äÀå : ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • °Å½Ã°æÁ¦Àû ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå·ü Àü¸Á
    • ¼¼°èÀÇ »óÀ§ ½ÃÀå °³¿ä
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ±ÔÁ¦¿Í ±â¼ú »óȲ

Á¦3Àå ¼¼°èÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018-2022³â)°ú ¿¹Ãø(2023-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ¼ö·®(À¯´Ö) ¿¹Ãø
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ëÀûÀÎ ±Ý¾× ±âȸ
  • ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2013-2016³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø, 2018-2026³â
  • ¼¼°èÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : Á¦Ç°
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • Á¦Ç°º° °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
      • ÀÚµ¿
      • ¹ÝÀÚµ¿
  • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ¿ëµµ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
      • ¸»ÃÊÇ÷°ü Á¶¿µ
      • ÁßÀçÀû ¹æ»ç¼±ÇÐ
      • Ç÷°ü ¼ö¼ú
      • ÁßÀçÀû ½ÉÀåÇÐ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ÀÀ¿ë
  • ¼¼°èÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
      • º´¿ø
      • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚ

Á¦4Àå ¼¼°èÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • Áö¿ªº° °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Áö¿ªº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª

Á¦5Àå ºÏ¹ÌÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018-2022³â)°ú ¿¹Ãø(2023-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ÀÚµ¿È­
    • ¹ÝÀÚµ¿
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¸»ÃÊÇ÷°ü Á¶¿µ
    • ÁßÀçÀû ¹æ»ç¼±ÇÐ
    • Ç÷°ü ¼ö¼ú
    • ÁßÀçÀû ½ÉÀåÇÐ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • º´¿ø
    • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦6Àå À¯·´ÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018-2022³â)°ú ¿¹Ãø(2023-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ÅÍŰ
    • ±âŸ À¯·´
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ÀÚµ¿
    • ¹ÝÀÚµ¿
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¸»ÃÊÇ÷°ü Á¶¿µ
    • ÁßÀçÀû ¹æ»ç¼±ÇÐ
    • Ç÷°ü ¼ö¼ú
    • ÁßÀçÀû ½ÉÀåÇÐ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • º´¿ø
    • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦7Àå µ¿¾Æ½Ã¾ÆÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018-2022³â)°ú ¿¹Ãø(2023-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ÀÚµ¿È­
    • ¹ÝÀÚµ¿
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¸»ÃÊÇ÷°ü Á¶¿µ
    • ÁßÀçÀû ¹æ»ç¼±ÇÐ
    • Ç÷°ü ¼ö¼ú
    • ÁßÀçÀû ½ÉÀåÇÐ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • º´¿ø
    • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦8Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018³â-2022³â)°ú ¿¹Ãø(2023³â-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • Àεµ
    • µ¿³²¾Æ½Ã¾Æ
    • ´ºÁú·£µå
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ ±âŸ Áö¿ª
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ÀÚµ¿È­
    • ¹ÝÀÚµ¿
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¸»ÃÊÇ÷°ü Á¶¿µ
    • ÁßÀçÀû ¹æ»ç¼±ÇÐ
    • Ç÷°ü ¼ö¼ú
    • ÁßÀçÀû ½ÉÀåÇÐ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • º´¿ø
    • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018³â-2022³â)°ú ¿¹Ãø(2023³â-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ÀÚµ¿
    • ¹ÝÀÚµ¿
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¸»ÃÊÇ÷°ü Á¶¿µ
    • ÁßÀçÀû ¹æ»ç¼±ÇÐ
    • Ç÷°ü ¼ö¼ú
    • ÁßÀçÀû ½ÉÀåÇÐ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • º´¿ø
    • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ CO2 ÀÎÁ§ÅÍ ½ÃÀå Àü¸Á : ½ÇÀû(2018³â-2022³â)°ú ¿¹Ãø(2023³â-2030³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °¡°Ý ºÐ¼®
  • °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
    • ±¹°¡º°
    • Á¦Ç°º°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
  • ±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • GCC
    • ÀÌÁýÆ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ºÏ¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Á¦Ç°º° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ÀÚµ¿È­
    • ¹ÝÀÚµ¿
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • ¸»ÃÊÇ÷°ü Á¶¿µ
    • ÁßÀçÀû ¹æ»ç¼±ÇÐ
    • Ç÷°ü ¼ö¼ú
    • ÁßÀçÀû ½ÉÀåÇÐ
  • ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾»ç¿ëÀÚº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
    • º´¿ø
    • Independent Cath Laboratories
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀïµµ ¸ÅÇÎ
    • °æÀï ¾Æ³¯·Î±× IC
    • º¸ÀÌ´Â Á¦Ç° ¿ë·®
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Angiodroid
    • Malek Medical GmbH
    • Optimed

Á¦12Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»ç ÀüÁ¦
  • µÎÀÚ¾î ¹× ¾à¾î
LSH 24.05.14

Market Research Projections has recently released an extensive analysis of the CO2 Injector Market, providing insights into critical market dynamics, growth drivers, challenges, and emerging trends. This report offers valuable data and statistics projecting the market's trajectory from 2023 to 2030, shedding light on the global landscape of CO2 injection systems.

The global CO2 injector market is forecast to expand at a CAGR of 6.2% and thereby increase from a value of US$11.7 Bn in 2023, to US$ 17.9 Bn by the end of 2030.

Key Insights:

  • CO2 Injector Market Size (2023 Estimate): USD 11.7 Billion
  • Projected Market Value (2030 Forecast): US$ 17.9 Billion
  • Global Market Growth Rate (CAGR 2023 to 2030):6.2%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 4.5%

CO2 Injector Market - Report Scope:

The CO2 injector market encompasses a range of technologies and systems designed for injecting carbon dioxide into various applications, including beverage carbonation, enhanced oil recovery (EOR), wastewater treatment, and greenhouse cultivation. These injectors play a crucial role in delivering CO2 for industrial processes, environmental applications, and agricultural practices. Market growth is driven by increasing demand for CO2-based technologies, rising environmental concerns, and the expansion of industries reliant on CO2 injection for process optimization and efficiency. The market remains dynamic, with ongoing innovations and advancements shaping the adoption of CO2 injection systems across diverse sectors.

Market Growth Drivers:

The global CO2 injector market is propelled by several factors, including the growing adoption of carbon capture and storage (CCS) technologies, the expansion of the beverage industry, and the rise in EOR activities. With mounting concerns over climate change and greenhouse gas emissions, there is a concerted effort to reduce CO2 emissions through CCS initiatives, driving the demand for CO2 injection systems for capturing and sequestering carbon dioxide from industrial processes. Additionally, the beverage industry's reliance on CO2 for carbonation presents significant opportunities for CO2 injector manufacturers. Furthermore, the utilization of CO2 for EOR applications in the oil and gas sector enhances oil recovery rates, stimulating market growth.

Market Restraints:

Despite favorable market conditions, the CO2 injector market faces challenges related to high installation costs, regulatory hurdles, and logistical constraints. The capital-intensive nature of CO2 injection systems, coupled with the need for specialized infrastructure and equipment, poses barriers to market entry for small and medium-sized enterprises (SMEs). Moreover, regulatory uncertainties surrounding CO2 emissions, storage, and transportation hinder market expansion, deterring investment in CCS projects and CO2 utilization initiatives. Additionally, logistical challenges associated with CO2 sourcing, supply chain management, and distribution further complicate the adoption of CO2 injection systems in remote or underserved regions.

Market Opportunities:

The global CO2 injector market stands poised to capitalize on emerging opportunities in renewable energy, agricultural practices, and industrial applications. With the transition towards renewable energy sources, there is a growing emphasis on bioenergy with carbon capture and storage (BECCS) technologies, which utilize CO2 injection to mitigate emissions from biomass combustion. Furthermore, the agricultural sector is exploring CO2 injection techniques for greenhouse cultivation, carbon sequestration in soils, and algae cultivation for biofuel production. Additionally, CO2 injection systems find applications in industrial processes such as chemical synthesis, wastewater treatment, and pH control, presenting diverse avenues for market expansion and innovation.

Key Questions Addressed in the Report:

  • Which regions are expected to lead the CO2 injector market in the coming years?
  • What factors are driving the demand for CO2 injection systems across different industries?
  • How will evolving regulatory frameworks and technological advancements impact the global CO2 injector market?
  • Who are the key players shaping the landscape of the CO2 injector market?
  • What are the key applications and end-user industries driving market growth in the CO2 injector sector?

Competitive Landscape and Business Strategies:

Major players in the global CO2 injector market, including Linde plc, Air Liquide S.A., and Praxair, Inc., focus on product innovation, strategic partnerships, and market expansion to maintain a competitive edge. These companies invest significantly in research and development to enhance injector efficiency, reliability, and environmental performance. Moreover, strategic collaborations with industry stakeholders, research institutions, and government agencies enable market players to access new markets, develop tailored solutions, and navigate regulatory challenges. By leveraging their technological expertise, global reach, and customer-centric approach, leading players aim to consolidate their market position and capitalize on emerging opportunities in the CO2 injector market.

Key Companies Profiled:

  • Linde plc
  • Air Liquide S.A.
  • Praxair, Inc.
  • Messer Group GmbH
  • Air Products and Chemicals, Inc.
  • Matheson Tri-Gas, Inc.
  • Taiyo Nippon Sanso Corporation
  • Universal Industrial Gases, Inc.
  • Gulf Cryo Holding C.S.C.
  • SOL Group

CO2 Injector Market Segmentation:

By Product:

  • Automated
  • Semi-automated

By Application:

  • Peripheral Angiography
  • Interventional Radiology
  • Vascular Surgery
  • Interventional Cardiology

By End User:

  • Hospitals
  • Independent Cath Laboratories

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global CO2 Injector Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. CO2 Injector Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global CO2 Injector Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Automated
      • 3.3.3.2. Semi-automated
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global CO2 Injector Market Outlook: Application
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
      • 3.5.3.1. Peripheral Angiography
      • 3.5.3.2. Interventional Radiology
      • 3.5.3.3. Vascular Surgery
      • 3.5.3.4. Interventional Cardiology
  • 3.6. Market Attractiveness Analysis: Application
  • 3.7. Global CO2 Injector Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.7.3.1. Hospitals
      • 3.7.3.2. Independent Cath Laboratories
  • 3.8. Market Attractiveness Analysis: End User

4. Global CO2 Injector Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Application
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Automated
    • 5.5.2. Semi-automated
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 5.6.1. Peripheral Angiography
    • 5.6.2. Interventional Radiology
    • 5.6.3. Vascular Surgery
    • 5.6.4. Interventional Cardiology
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.7.1. Hospitals
    • 5.7.2. Independent Cath Laboratories
  • 5.8. Market Attractiveness Analysis

6. Europe CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Application
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Automated
    • 6.5.2. Semi-automated
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 6.6.1. Peripheral Angiography
    • 6.6.2. Interventional Radiology
    • 6.6.3. Vascular Surgery
    • 6.6.4. Interventional Cardiology
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.7.1. Hospitals
    • 6.7.2. Independent Cath Laboratories
  • 6.8. Market Attractiveness Analysis

7. East Asia CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Application
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Automated
    • 7.5.2. Semi-automated
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 7.6.1. Peripheral Angiography
    • 7.6.2. Interventional Radiology
    • 7.6.3. Vascular Surgery
    • 7.6.4. Interventional Cardiology
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.7.1. Hospitals
    • 7.7.2. Independent Cath Laboratories
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Automated
    • 8.5.2. Semi-automated
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 8.6.1. Peripheral Angiography
    • 8.6.2. Interventional Radiology
    • 8.6.3. Vascular Surgery
    • 8.6.4. Interventional Cardiology
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.7.1. Hospitals
    • 8.7.2. Independent Cath Laboratories
  • 8.8. Market Attractiveness Analysis

9. Latin America CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Automated
    • 9.5.2. Semi-automated
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 9.6.1. Peripheral Angiography
    • 9.6.2. Interventional Radiology
    • 9.6.3. Vascular Surgery
    • 9.6.4. Interventional Cardiology
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.7.1. Hospitals
    • 9.7.2. Independent Cath Laboratories
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa CO2 Injector Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Automated
    • 10.5.2. Semi-automated
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 10.6.1. Peripheral Angiography
    • 10.6.2. Interventional Radiology
    • 10.6.3. Vascular Surgery
    • 10.6.4. Interventional Cardiology
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.7.1. Hospitals
    • 10.7.2. Independent Cath Laboratories
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Angiodroid
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Malek Medical GmbH
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Optimed
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦